Longitude Capital Partners III LLC 13D and 13G filings for Sierra Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-05-06 4:33 pm Sale |
2022-04-27 | 13D | Sierra Oncology, Inc. SRRA |
Longitude Capital Partners III LLC | 1,485,140 5.700% |
-2,140,130 (-59.03%) |
Filing |
| 2022-02-04 5:22 pm Purchase |
2022-01-25 | 13D | Sierra Oncology, Inc. SRRA |
Longitude Capital Partners III LLC | 3,625,270 17.400% |
175,000 (+5.07%) |
Filing |
| 2021-11-08 07:58 am Purchase |
2021-11-03 | 13D | Sierra Oncology, Inc. SRRA |
Longitude Capital Partners III LLC | 3,450,270 20.300% |
1,972,450 (+133.47%) |
Filing |